NEW YORK, June 6, 2026, 11:03 EDT
- Clorox jumped 5.03% to finish at $94.14 on Friday. The S&P 500 dropped 2.64%.
- The NYSE is shut for the weekend. When trading starts Monday, investors will see if the defensive bid stays in place.
- Investors deal with CEO-transition risk and softer organic sales guidance, while U.S. inflation data is due next week.
Clorox stock bounced Friday, bucking a sharp Wall Street selloff. The household-products maker caught a lift at the end of the week, coming off a rough patch after cutting guidance and swapping CEOs with little warning.
The stock added 5.03% to close at $94.14, logging back-to-back gains. S&P 500 slipped 2.64%, and the Dow dropped 1.35%. Trading volume hit 3.3 million shares, topping the 50-day average, according to MarketWatch. MarketWatch
Investors were looking for safety, so the timing of the move mattered. Consumer staples, the group selling basics like cleaning products, food, and household items, tend to attract buyers when investors leave growth stocks and dial down risk.
U.S. markets are closed for the weekend, according to the NYSE’s 2026 calendar. The next regular session is Monday, June 8. Clorox gets a break after shares rose 4.6% this week, moving from $90.02 at Thursday’s close to $94.14 at Friday’s finish.
Clorox bounced Friday, but that wasn’t enough to fix the drop. The stock was still down 28.7% from its 52-week high of $132.03, hit last July. Procter & Gamble and Colgate-Palmolive also advanced, up roughly 4.1% each. The move didn’t look like just a Clorox story.
Clorox shares are still moving on the CEO news. On May 28, the company said Chair and CEO Linda Rendle told the board to start looking for a new chief as she deals with health issues. Rendle will remain in her role until Clorox picks a successor. She called it an “incredibly difficult” choice. Lead independent director Matthew J. Shattock said Rendle led the company through “transformation and volatility.” The Clorox Company Investors
Operating momentum is where investors are focused. Clorox posted flat fiscal Q3 sales at $1.67 billion in late April. Organic sales fell 1%, and gross margin narrowed by 140 basis points to 43.2%. That’s sales excluding deals and currency changes. Adjusted EPS climbed 13% to $1.64. But Clorox also lowered its fiscal 2026 outlook, now calling for adjusted EPS of $5.45 to $5.65 and organic sales down about 9%. Rendle said there’s “more work to do” in a “challenging consumer and cost environment.” The Clorox Company Investors
Clorox is folding in GOJO Industries, the Purell maker it finished acquiring on April 1. The pickup gives Clorox more health and hygiene exposure on top of Clorox, Pine-Sol, Glad, Brita, Burt’s Bees, Hidden Valley and Fresh Step. But the deal brings transaction costs and new debt pressure that will weigh on near-term earnings.
Clorox got a lift Friday, but that might not last if investors see the move as just defensive rotation, not real confidence in the company. Risks include a slow recovery in market share, rising costs in manufacturing and logistics, soft demand, a long CEO search, or another guidance cut. Any of those could drag the stock down again.
Little letup is expected from macro forces in the week ahead. The NYSE’s Friday market recap called out the strong jobs report for driving Treasury yields up and pointed to inflation data—CPI and PPI—as next week’s focus. Higher rates often drag on stocks by cutting the value of future earnings and raising borrowing costs. New York Stock Exchange
Clorox opens Monday with a test for its recent move. If shares keep Friday’s gains, the market could be showing some patience for management as it works through execution issues and a leadership shift. If the stock falls, it looks like one good day last week isn’t enough for investors.
